Thursday, August 6, 2026 Login
Breaking
‘Save me’: Eyewitness recounts Atiq Ahmed’s son Abaan’s last words after fatal crash | Lucknow News Two coasts, three fee formulas, one Supreme Leader still to sign: The versions of Iran-Oman deal on Strait of Hormuz | Hindustan Times – hindustantimes.com Box Office Analysis: Spider-Man: Brand New Day is pan-India in footfalls, English-led in revenue; 3D powers 77% of six-day business :Bollywood Box Office Tom Clancy’s Ghost Recon Wildlands Launches Last Rites Update To Celebrate The Series 25th Anniversary The human cost of the AI revolution
Business

Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo – Reuters

By cpstestersofficial@gmail.com · August 6, 2026 · 1 min read

  1. Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo  Reuters
  2. Lilly’s Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk  ET Pharma
  3. GLP-1 drugs are driving higher sales for Eli Lilly and Novo Nordisk – National  Global News
  4. Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress  Eli Lilly and Company
  5. Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge  CNBC

Source link

Facebook X / Twitter WhatsApp

Related Stories

Leave a Comment

Your email address will not be published. Required fields are marked *